1Victorino GP, Newton CR, Curran B. Modulation of microvascular hydraulic permeability by platelet-activating factor. J Trauma,2004, 56: 379-384.
2Klabunde RE, Anderson DE. Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. J Vasc Res, 2002, 39: 238-245.
3Morigi M, Macconi D, Riccardi E, et al. Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice. J Pharmacol Exp Ther, 1991, 258: 601-606.
4Clark WF, Muir AD, Westcott ND, et al. A novel treatment for lupus nephritis: lignan precursor derived from flax. Lupus, 2000,9: 429-436.
5Lie WJ, Homburg CH, Kuijpers TW, et al. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. Clin Exp Allergy, 2003, 33: 1125-1134.
6Kilgore KS, Ward PA, Warren JS. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor. Inflammation,1998, 22: 583-598.
8Patrignani P, Valitutti S, Aiello F, et al. Platelet-activating factor(PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation. Biochem Biophys Res Commun, 1987, 148: 802-810.
9Orlov SM, Vlasov AA, Lipatkina L, et al. Mechanism of suppression of human peripheral blood lymphocyte proliferation by platelet activation factor. Biull Eksp Biol Med, 1989, 108: 69-71.
10Hidi R, Timmermans S, Liu E, et al. Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. Eur Respir J, 2000, 15: 342-349.
3Mok CC,Lee KW,Ho CT,et al.A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a Southern Chinese population[J].Reumatology(Oxfoud),2000,39:399-406
4American College of Rheumatology and A Conunittee on Systemi Lupus Erythematosus.Guidelines for referral and management of systemic lupus erythematosus in adults[J].Arthritis Rheum,1999,42:1785-1796
5Victorino GP,Newton CR.Curran B Modulation of microvasculahydraulic permeability by platelet activating factor[J].J Trauma,2004,56:379-384
6Mok CC, Lee KW, HO CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a Southern Chinese population[J]. Reumatology (Oxfoud), 2000,39:399-406.
7American College of Rheumatology and A Conunittee on Systemic Lupus Erythematosus. Guidelines for referral and management of systemic lupus erythematosus in adults[J]. Arthritis Rheum, 1999,42: 1785-1796.
8Victorino GP, Newton CR, Curran B. Modulation of microvascular hydraulic permeability by platelet-activating factor [J]. J Trauma, 2004,56:379-384.
